文献速递生殖医学

特发性早期卵巢衰老:全国性队列研究中辅助生殖技术后的流产风险与分娩机会

Idiopathic early ovarian ageing: risk of miscarriage and chance of delivery following ART in a nationwide cohort study.
PubMed 文献 · Hum Reprod · 2022-01-01

这项丹麦全国注册历史性队列研究纳入1995-2014年辅助生殖技术治疗周期,比较特发性早期卵巢衰老(EOA)与正常卵巢衰老(NOA)年轻女性的妊娠丢失风险及临床妊娠和活产机会。EOA组整体妊娠丢失风险与NOA组相当(校正风险比1.04,95%CI 0.86;1.26),但每次胚胎移植的临床妊娠和活产几率较低(校正比值比分别为0.77和0.78)。

要点

  • EOA组整体妊娠丢失风险与NOA组相当,校正风险比1.04(95%CI 0.86;1.26)。
  • 按妊娠丢失类型分层后,EOA组与NOA组风险仍相当。
  • EOA组每次胚胎移植临床妊娠和活产几率低于NOA组,校正比值比分别为0.77和0.78。

核心结论

  • 年轻女性特发性卵泡加速丢失表现为与正常卵巢储备年轻女性相似的妊娠丢失风险,但每次胚胎移植临床妊娠和活产几率较低。
  • 作者认为本研究发现可能提示,除非整倍体外的其他机制可解释EOA患者按年龄正常的流产风险与降低的着床机会之间的不同步。
  • 作者认为本研究结果在向卵巢储备低的年轻患者提供咨询时可能有价值。

研究设计与样本

  • 丹麦全国注册历史性队列研究,纳入1995-2014年丹麦公立或私立生殖诊所辅助生殖技术治疗周期。
  • 研究对象为≤37岁年轻女性,按卵巢储备状态分为早期卵巢衰老(EOA)组和正常卵巢衰老(NOA)组。
  • EOA组有2734个合格周期,NOA组有22573个合格周期;其中EOA组1874个周期(1213名女性)和NOA组19526个周期(8814名女性)进行了胚胎移植并纳入分析。
  • EOA定义为第一和第二周期促卵泡激素刺激后均获卵≤5个;NOA组需至少两个促卵泡激素刺激周期,且第一或第二周期获卵≥8个。
  • 排除已知影响卵巢储备的病例(子宫内膜异位症、卵巢手术、多囊卵巢综合征、化疗等)。

主要发现

  • EOA组整体妊娠丢失风险与NOA组相当,校正风险比1.04(95%CI 0.86;1.26)。
  • 按妊娠丢失类型分层后,EOA组与NOA组风险相当。
  • EOA组每次胚胎移植获得临床妊娠的校正比值比为0.77(95%CI 0.67;0.88),低于NOA组。
  • EOA组每次胚胎移植获得活产的校正比值比为0.78(95%CI 0.67;0.90),低于NOA组。

关键数值与推荐

  • 主要结局为hCG阳性后整体妊娠丢失风险(孕龄≤22周),并分层为非可见妊娠丢失、早期流产(孕龄≤12周)和晚期流产(孕龄>12周)。
  • 次要结局为每次胚胎移植的临床妊娠机会和活产机会。
  • 采用Cox回归模型评估妊娠丢失风险,时间-事件从第二周期及后续周期的胚胎移植日开始计算。
  • 采用逻辑回归模型评估临床妊娠和活产机会。

临床怎么用

  • 作者认为本研究结果在向卵巢储备低的年轻患者提供咨询时可能有价值。
  • 原文未据此给出推荐。

局限性

  • 仅纳入至少有两个辅助生殖技术周期的女性。
  • 无每个周期促性腺激素总剂量的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is idiopathic reduced ovarian reserve in young women, quantified as low response to ovarian stimulation in ART, associated with a concomitant loss of oocyte quality as determined by risk of pregnancy loss and chance of clinical pregnancy and live birth? SUMMARY ANSWER: Young women with idiopathic accelerated loss of follicles exhibit a similar risk of pregnancy loss as young women with normal ovarian reserve. WHAT IS KNOWN ALREADY: Normal ovarian ageing is described as a concomitant decline in oocyte quantity and quality with increasing age. Conflicting results exist with regard to whether a similar decline in oocyte quality also follows an accelerated loss of follicles in young women. STUDY DESIGN, SIZE, DURATION: This national register-based, historical cohort study included treatment cycles from young women (≤37 years) after ART treatment in Danish public or private fertility clinics during the period 1995-2014. The women were divided into two groups dependent on their ovarian reserve status: early ovarian ageing (EOA) group and normal ovarian ageing (NOA) group. There were 2734 eligible cycles in the EOA group and 22 573 in the NOA group. Of those, 1874 (n = 1213 women) and 19 526 (n = 8814 women) cycles with embryo transfer were included for analyses in the EOA and NOA group, respectively. PARTICIPANTS/MATERIALS, SETTING, METHODS: EOA was defined as ≤5 oocytes harvested in both the first and second cycle stimulated with FSH. The NOA group should have had at least two FSH-stimulated cycles with ≥8 oocytes harvested in either the first or the second cycle. Cases with known causes influencing the ovarian reserve (endometriosis, ovarian surgery, polycystic ovary syndrome, chemotherapy, etc.) were excluded. The oocyte quality was evaluated by the primary outcome defined as the overall risk of pregnancy loss (gestational age (GA) ≤22 weeks) following a positive hCG and further stratified into: non-visualized pregnancy loss, early miscarriage (GA ≤ 12 weeks) and late miscarriage (GA > 12 weeks). Secondary outcomes were chance of clinical pregnancy and live birth per embryo transfer. Cox regression models were used to assess the risk of pregnancy loss. Time-to-event was measured from the day of embryo transfer from the second cycle and subsequent cycles. Logistic regression models were used to assess the chance of clinical pregnancy and live birth. MAIN RESULTS AND THE ROLE OF CHANCE: The overall risk of pregnancy loss for the EOA group was comparable with the NOA group (adjusted hazard ratio: 1.04, 95% CI: 0.86; 1.26). Stratifying by pregnancy loss types showed comparable risks in the EOA and NOA group. The odds of achieving a clinical pregnancy or live birth per embryo transfer was lower in the EOA group compared to the NOA group (adjusted odds ratio: 0.77 (0.67; 0.88) and 0.78 (0.67; 0.90), respectively). LIMITATIONS, REASONS FOR CAUTION: Only women with at least two ART cycles were included. We had no information on the total doses of gonadotropin administered in each cycle. WIDER IMPLICATIONS OF THE FINDINGS: The present findings may indicate that mechanism(s) other than aneuploidy may explain the asynchrony between the normal-for-age risk of miscarriage and the reduced chance of implantation found in our patients with EOA. The results of this study could be valuable when counselling young patients with low ovarian reserve. STUDY FUNDING/COMPETING INTERESTS(S): The study was funded by the Health Research Fund of Central Denmark Region. The authors have no conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Christensen MW, Ingerslev HJ, Kirkegaard K, et al. Idiopathic early ovarian ageing: risk of miscarriage and chance of delivery following ART in a nationwide cohort study. Hum Reprod. 2022. PMID: 35522192. doi:10.1093/humrep/deac093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。